Company intelligence / Profile preview

D-TARGET

Geneva, Geneva, Switzerland

Ownership: Private
Development stage: Other

Overview

D-Target was a Swiss-based Contract Research Organization (CRO) that specialized in providing clinical and regulatory services for the medical device and diagnostic industries. Founded in 2006, the company offered comprehensive support for manufacturers, including clinical trial design, trial management, regulatory strategy, and quality assurance. D-Target was particularly recognized for its expertise in navigating the complex European regulatory landscape and helping clients achieve CE marking for high-risk medical devices. In April 2015, the company was acquired by Voisin Consulting Life Sciences (VCLS) to strengthen VCLS's global medical device and in vitro diagnostic (IVD) capabilities.

Modalities: Device
Industry: Contract Research Organization

Beyond the preview

Go deeper on D-TARGET.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on D-TARGET.

Explore the full profile